ISSN: 1527-6465

Journal Home

Journal Guideline

Liver Transplantation Q1 Unclaimed

Wolters Kluwer Health United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Liver Transplantation is a journal indexed in SJR in Hepatology and Surgery with an H index of 169. It has a price of 2395 €. It has an SJR impact factor of 1,7 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,7.

Liver Transplantation focuses its scope in these topics and keywords: liver, transplantation, hepatocellular, impact, disease, living, pediatric, failure, autoimmune, outcome, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Hepatology (Q1) Surgery (Q1) Transplantation (Q1)

Price

2395 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

1,7

SJR Impact factor

169

H Index

209

Total Docs (Last Year)

759

Total Docs (3 years)

4475

Total Refs

1896

Total Cites (3 years)

459

Citable Docs (3 years)

2.36

Cites/Doc (2 years)

21.41

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Journal of Hepatology Q1
Nature Reviews Gastroenterology and Hepatology Q1
Lancet Gastroenterology and Hepatology, The Q1
The Lancet Gastroenterology and Hepatology Q1
Gastroenterology Q1

Compare this journals

Aims and Scope

Best articles by citations

Orthotopic liver transplantation for alcoholic liver disease: A retrospective analysis of survival, recidivism, and risk factors predisposing to recidivism

Orthotopic liver transplantation in human immunodeficiency virus (HIV)-positive patients: Outcome of 7 patients from the Bonn cohort

The use of hepatitis C-infected grafts in liver transplantation

Ethical issues surrounding adult-to-adult living donor liver transplantation

Hepatic and intestinal schistosomiasis after orthotopic liver transplant

Rejection of pig liver xenografts in patients with liver failure: Implications for xenotransplantation

Double-dose accelerated hepatitis B vaccine in patients with end-stage liver disease

Rho-kinase inhibitor targeting the liver prevents ischemia/reperfusion injury in the steatotic liver without major systemic adversity in rats

Renal outcomes after liver transplantation in the model for end-stage liver disease era

Hepatopulmonary syndrome after living donor liver transplantation and deceased donor liver transplantation: A single-center experience

Influenza Infection in Patients Before and After Liver Transplantation

Differences in lymphocyte gene expression between tolerant and syngeneic liver grafted rats

SHOW MORE ARTICLES

Cognitive dysfunction and health-related quality of life in long-term liver transplant survivors

Recurrent hepatitis C virus infection after orthotopic liver transplantation

Bronchiolitis obliterans organizing pneumonia after orthotopic liver transplantation

Graft-versus-host disease following living donor liver transplantation

Is the Cost of Adult Living Donor Liver Transplantation Higher Than Deceased Donor Liver Transplantation?

Prophylactic and preemptive therapies for hepatitis C virus-infected patients undergoing liver transplantation

Osteopenia and osteoporosis in patients with end-stage liver disease caused by hepatitis C and alcoholic liver disease: Not just a cholestatic problem

Refinement of venous reconstruction using cryopreserved veins in right liver grafts

Patient and graft survival in hepatitis C recipients after adult living donor liver transplantation in the United States

Treatment of patients with hepatitis C virus on the waiting list

Host and donor risk factors before and after liver transplantation that impact HCV recurrence

Hepatitis C virus therapy, hepatocyte drug metabolism, and risk for acute cellular rejection